Wisconsin Institute for Immune and Cell Therapy Inc

Nonprofit profile at a glance

EIN
871500208
IRS 990 coverage
2022–2025
Forms available
Form 990 2025, Form 990-EZ 2021
Location
Madison, WI, USA
Phone
6087291450
Rating
74
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Medical Research N.E.C.

Reported finances

Revenue
$633,111
Expenses
$361,002
Assets
$2,083,502
Liabilities
$3,135

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

3 people listed

Executive titles in this filing

  • GARY A DAHL (PRESIDENT)

People named in this filing

  • GARY A DAHL (PRESIDENT)
  • JEROME J JENDRISAK (VP, SEC/TREA)
  • KIERAN COE (DIRECTOR)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The organization's primary exempt purpose is to engage in the continuous active conduct of medical research in conjunction with a hospital.

What it reported doing in 2025

In 2025, wiict worked as a collaborator with researchers and clinicians from institutions including: st. Jude's children's hospital, national institute for allergy and infectious disease/national institutes of health, Massachusetts general hospital and Massachusetts general brigham. Collaborations included the production of research-grade mrnas for use in the discovery process for both gene replacement and genome-editing-based therapeutic treatments as well as ongoing research into future iterations (next generation) forms of these treatments. Wiict also produced gmp-grade mrnas for use in both gene replacement and genome-editing-based therapeutic treatments in fda-sanctioned clinical trials. One example is the successful treatment of the first ever in human gene therapy to treat and cure x-linked hyper igm syndrome (cd40 ligand deficiency), a serious immunodeficiency disease.

Operating model

Revenue model
Donor-supported. 91% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and a large share of total spending goes to programs. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 60
  • Transparency & Controls: 92
  • Accountability: 76
  • Sustainability: 84
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 54.6%; rating input score 55
  • Program expense ratio: 87.8%; rating input score 88
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 3 of 7 controls in place; rating input score 43
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 43%; rating input score 88; 88th percentile among comparable filings
  • Total-asset coverage ratio: 5.77; rating input score 86; 86th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 71; 71st percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

  • Program expense growth: -3.8% per year; rating input score 0; 8th percentile among comparable filings
  • Revenue growth: 34.6% per year; rating input score 100; 92nd percentile among comparable filings
  • Asset growth: 64.3% per year; rating input score 100; 97th percentile among comparable filings

Details

  • Where the money goes: 54.6% of revenue deployed · 87.8% of spending went to programs
  • Governance: 3 of 3 board members independent · 3 of 7 filing controls reported
  • Programs: 1 filed program accomplishment · $317K in reported program spending
  • Leadership: top reported pay $0 · 3 people listed
  • Consistency: 17 of 17 current checks pass
  • Schedules: 4 filed schedules · includes major donors
  • Filing history: 4 filing years from 2022 to 2025
  • Contacts: How to reach this organization
  • Related organizations: 2 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Mission deployment rate scored 55/100.
  • Moderate — Accountability: Governance controls: 3 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.